Superoxide dismutase activity confers (p)ppGpp-mediated antibiotic tolerance to stationary-phase Pseudomonas aeruginosa

Proc Natl Acad Sci U S A. 2018 Sep 25;115(39):9797-9802. doi: 10.1073/pnas.1804525115. Epub 2018 Sep 10.

Abstract

Metabolically quiescent bacteria represent a large proportion of those in natural and host environments, and they are often refractory to antibiotic treatment. Such drug tolerance is also observed in the laboratory during stationary phase, when bacteria face stress and starvation-induced growth arrest. Tolerance requires (p)ppGpp signaling, which mediates the stress and starvation stringent response (SR), but the downstream effectors that confer tolerance are unclear. We previously demonstrated that the SR is linked to increased antioxidant defenses in Pseudomonas aeruginosa We now demonstrate that superoxide dismutase (SOD) activity is a key factor in SR-mediated multidrug tolerance in stationary-phase P. aeruginosa Inactivation of the SR leads to loss of SOD activity and decreased multidrug tolerance during stationary phase. Genetic or chemical complementation of SOD activity of the ΔrelA spoT mutant (ΔSR) is sufficient to restore antibiotic tolerance to WT levels. Remarkably, we observe high membrane permeability and increased drug internalization upon ablation of SOD activity. Combined, our results highlight an unprecedented mode of SR-mediated multidrug tolerance in stationary-phase P. aeruginosa and suggest that inhibition of SOD activity may potentiate current antibiotics.

Keywords: (p)ppGpp stringent response; Pseudomonas aeruginosa; antibiotic tolerance; stationary phase; superoxide dismutase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Dose-Response Relationship, Drug
  • Drug Resistance, Multiple, Bacterial*
  • Gentamicins / pharmacology
  • Ligases / metabolism
  • Meropenem
  • Microbial Sensitivity Tests
  • Ofloxacin / pharmacology
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / enzymology
  • Signal Transduction
  • Superoxide Dismutase / metabolism*
  • Superoxide Dismutase / physiology
  • Thienamycins / pharmacology

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Thienamycins
  • Ofloxacin
  • Superoxide Dismutase
  • Ligases
  • guanosine 3',5'-polyphosphate synthetases
  • Meropenem

Grants and funding